Latest stories on RAPP
Stifel reiterates Rapport Therapeutics stock rating on epilepsy drug outlook
Investing.com Analyst Ratings56 · neutralanalyst
Rapport Therapeutics price target raised to $75 from $65 at BTIG
The Fly61 · neutralanalyst
BTIG raises Rapport Therapeutics price target to $75 on RAP-219
Investing.com Analyst Ratings61 · neutralanalyst
Truist reiterates Buy on Rapport Therapeutics stock ahead of data
Investing.com Analyst Ratings61 · neutralanalyst
Rapport Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Rapport Therapeutics to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program
GlobeNewswire56 · neutralproduct/pr
Rapport Therapeutics: A 22-Day Half-Life Creates A Differentiated Epilepsy Franchise
Seeking Alpha63 · neutralproduct/pr
Rapport Therapeutics price target raised to $75 from $68 at Raymond James
The Fly61 · neutralanalyst
Raymond James raises Rapport Therapeutics price target on bipolar catalyst potential
Investing.com Analyst Ratings61 · neutralanalyst
Rapport Therapeutics reports Q2 results
Seeking Alpha34 · bearishearnings
Rapport Therapeutics, Inc. (RAPP) files 8-K
SEC 8-K50 · neutralgeneral
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
StockTitan50 · neutralgeneral
William Blair initiates Rapport Therapeutics stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?
The Motley Fool38 · neutralgeneral
Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now?
Yahoo Finance57 · neutralanalyst
Rapport Therapeutics Holds 2026 Annual Shareholder Meeting
TipRanks50 · neutralgeneral
Rapport Therapeutics, Inc. (RAPP) files 8-K
SEC 8-K50 · neutralgeneral
Rapport Therapeutics, Inc. (RAPP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
BTIG Raises its Price Target on Rapport Therapeutics (RAPP)
Yahoo Top61 · neutralanalyst
RAPP Advances RAP-219 Into Phase 3, Raising the Stakes in Focal Epilepsy
TipRanks73 · bullishproduct/pr